Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells
- PMID: 11295051
- DOI: 10.3892/ijo.18.5.1023
Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells
Abstract
The sensitivity of non-isotopic PCR-SSCP was compared to direct sequencing of PTEN exons. DNA from leukocytes derived from healthy donors, and from the glioblastoma cell line LN319 was extracted and mixed in different proportions from 0 to 100%. The LN319 cell line contains a point mutation at codon 15 exon 1 of the PTEN gene. The PCR-SSCP experiments demonstrated mutations in samples containing as little as 10% tumor DNA. In contrast, direct DNA sequencing experiments were less sensitive, requiring 30-70% of tumor DNA in the sample, depending on the DNA strand sequenced. In conclusion, PCR-SSCP, in our hands, is more sensitive than automated sequencing for detecting PTEN point mutations. We recommend to always sequence both strands, and take into account that samples containing less than 30% tumor cells should not only be sequenced, but also studied by PCR-SSCP in order to discriminate false negative results.
Similar articles
-
p53 and PTEN gene mutations in gemistocytic astrocytomas.Acta Neuropathol. 1998 Jun;95(6):559-64. doi: 10.1007/s004010050840. Acta Neuropathol. 1998. PMID: 9650746
-
Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.Mol Pathol. 1999 Dec;52(6):353-6. doi: 10.1136/mp.52.6.353. Mol Pathol. 1999. PMID: 10748870 Free PMC article.
-
Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.J Neuropathol Exp Neurol. 1999 Nov;58(11):1170-83. doi: 10.1097/00005072-199911000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10560660
-
PTEN mutations in malignant gliomas and their relation with meningeal gliomatosis.J Neurooncol. 2001 May;53(1):21-6. doi: 10.1023/a:1011839920176. J Neurooncol. 2001. PMID: 11678426
-
Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.Cancer Lett. 2002 Apr 8;178(1):43-51. doi: 10.1016/s0304-3835(01)00815-1. Cancer Lett. 2002. PMID: 11849740
Cited by
-
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.J Thorac Oncol. 2013 Jul;8(7):823-59. doi: 10.1097/JTO.0b013e318290868f. J Thorac Oncol. 2013. PMID: 23552377 Free PMC article.
-
[The detection methods of EGFR mutations in non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):297-302. doi: 10.3779/j.issn.1009-3419.2011.03.18. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21426678 Free PMC article. Review. Chinese. No abstract available.
-
[Treatment progress for EGFR wild-type advanced non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2014 Jul 20;17(7):575-80. doi: 10.3779/j.issn.1009-3419.2014.07.14. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25034590 Free PMC article. Review. Chinese.
-
A mutation-sensitive switch assay to detect five clinically significant epidermal growth factor receptor mutations.Genet Test Mol Biomarkers. 2015 Jun;19(6):316-23. doi: 10.1089/gtmb.2014.0329. Epub 2015 Apr 28. Genet Test Mol Biomarkers. 2015. PMID: 25918867 Free PMC article.
-
Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung Cancer.PLoS One. 2016 Sep 29;11(9):e0163652. doi: 10.1371/journal.pone.0163652. eCollection 2016. PLoS One. 2016. PMID: 27685950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials